MannKind(美国)

MannKind Corporation

美国MannKindCorporation www.mannkindcorp.com胰岛素吸入设备生产商MannKindCorpMannKindCorporation(Nasdaq:MNKD)isabiopharmaceuticalcompanythatfocusesonthediscovery,developmentandcommercializationoftherapeuticproduct sfordiseasessuchasdiabetesandcancer.Ourleadinvestigationalproductcandidate,AFREZZA™,isanultrarapid-actinginsulin.WehavesubmittedanewdrugapplicationtotheFDArequestingapprovalofAFREZZAforthetreatmentofadultswithtype1ortype2diabetesforthecontrolofhyperglycemia.ThepharmacokineticprofileofAFREZZAsetsitapartfromallotherinsulinproducts.AFREZZAparticlesdissolveuponcontactwiththelungsurface,releasinginsulinthatrapidlyentersthebloodstream.Itachievespeakinsulinlevelswithin12-14minutesofadministration,whichmorecloselymimicsthenaturalreleaseofinsulinthananyotherinsulinpreparation.Inourclinicaltrials,wehaveobservedthatp